Moderna, Inc.
MRNA- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001682852
In the last 90 days, Moderna, Inc. insiders filed 0 open-market purchases and 5 sales; 784 institutions reported holding it in 13F filings for Q2 2026, worth $22.3B in total; no superinvestor holds it.
Superinvestors holding MRNA, Q2 2026
No superinvestor reported holding MRNA in Q2 2026.
Moves by quarter
Superinvestors that opened, added to, trimmed or sold out of MRNA each quarter, comparing shares with the quarter before. A superinvestor that didn't file for a quarter isn't listed, and isn't counted as selling.
Q1 2026
0 superinvestors holding at quarter end
- Sold out
- Coatue Management
Q4 2025
1 superinvestor holding at quarter end
Q2 2025
0 superinvestors holding at quarter end
- Sold out
- H&H International Investment
Q1 2025
1 superinvestor holding at quarter end
- Reduced
- H&H International Investment (−49.1%)
- Sold out
- Coatue Management
Q4 2024
2 superinvestors holding at quarter end
- New
- Coatue Management
- Added
- H&H International Investment (+66.8%)
- Sold out
- ARK Invest
Q3 2024
2 superinvestors holding at quarter end
- Added
- ARK Invest (+10.4%)
- Reduced
- H&H International Investment (−30.6%)
Q2 2024
2 superinvestors holding at quarter end
- Reduced
- ARK Invest (−13.4%)
Q1 2024
2 superinvestors holding at quarter end
- Added
- ARK Invest (+178.3%), H&H International Investment (+0.1%)
- Sold out
- Coatue Management
Q4 2023
3 superinvestors holding at quarter end
- Added
- ARK Invest (+68.3%), H&H International Investment (+35.1%)
- Reduced
- Coatue Management (−33.3%)
Q3 2023
3 superinvestors holding at quarter end
- Added
- ARK Invest (+81.7%)
- Reduced
- Coatue Management (−25.0%), H&H International Investment (−25.7%)
- Sold out
- Lone Pine Capital
Q2 2023
4 superinvestors holding at quarter end
- Reduced
- ARK Invest (−4.0%), H&H International Investment (−6.7%)
- Sold out
- Duquesne Family Office
Q1 2023
5 superinvestors holding at quarter end
- Added
- Coatue Management (+2.4%), Lone Pine Capital (+13.1%)
- Reduced
- H&H International Investment (−6.3%), ARK Invest (−1.4%)
- Sold out
- HHLR Advisors (Hillhouse)
Q4 2022
6 superinvestors holding at quarter end
- New
- Lone Pine Capital, HHLR Advisors (Hillhouse)
- Added
- Coatue Management (+12.0%)
- Reduced
- ARK Invest (−7.7%)
Q3 2022
4 superinvestors holding at quarter end
- New
- ARK Invest
- Added
- Coatue Management (0.0%)
- Reduced
- Duquesne Family Office (−89.3%)
Q2 2022
3 superinvestors holding at quarter end
- New
- Duquesne Family Office
- Reduced
- Coatue Management (−17.6%)
Q1 2022
2 superinvestors holding at quarter end
- Added
- Coatue Management (+61.6%), H&H International Investment (+166.7%)
Q4 2021
2 superinvestors holding at quarter end
- New
- H&H International Investment
- Reduced
- Coatue Management (−29.1%)
- Sold out
- Lone Pine Capital, Duquesne Family Office
Q3 2021
3 superinvestors holding at quarter end
- Reduced
- Coatue Management (−1.5%), Lone Pine Capital (−16.9%), Duquesne Family Office (−61.3%)
Q2 2021
3 superinvestors holding at quarter end
- New
- Lone Pine Capital, Duquesne Family Office
- Added
- Coatue Management (+388.3%)